These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22544372)

  • 1. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).
    Baumunk D; Reichelt U; Hildebrandt J; Krause H; Ebbing J; Cash H; Miller K; Schostak M; Weikert S
    World J Urol; 2013 Oct; 31(5):1191-6. PubMed ID: 22544372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
    Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
    Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
    Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
    Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
    Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
    Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B
    Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
    Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
    Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis].
    Wu F; Liang YQ; Huang ZM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):203-6. PubMed ID: 19335984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways.
    Yu Z; Li Q; Zhang G; Lv C; Dong Q; Fu C; Kong C; Zeng Y
    Int J Oncol; 2019 Jul; 55(1):81-92. PubMed ID: 31180521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
    Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
    Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
    Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
    Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.
    Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.
    Li C; Li H; Zhang T; Li J; Ma F; Li M; Sui Z; Chang J
    Med Sci Monit; 2015 Nov; 21():3380-5. PubMed ID: 26540164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
    Nikitenko LL; Leek R; Henderson S; Pillay N; Turley H; Generali D; Gunningham S; Morrin HR; Pellagatti A; Rees MC; Harris AL; Fox SB
    Clin Cancer Res; 2013 Oct; 19(20):5740-8. PubMed ID: 23969937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.